High Court Stays Mum On Teva MS Drug Patent Suit
The U.S. Supreme Court on Monday took no action for a second time in a patent case over Teva Pharmaceuticals USA Inc.'s lucrative multiple sclerosis drug Copaxone, as the clock ticks...To view the full article, register now.
Already a subscriber? Click here to view full article